MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Diabetes (Glucometers, Glucose Monitoring, Continuous Glucose Monitoring [CGM] Companies)
Know Labs, Inc. (NYSE_KNW)*
Organization & Developments: Know Labs
Parents
Know Labs, Inc. (NYSE_KNW)*
Children
2023: Know Labs Demonstrates Accuracy of Non-Invasive, Bio-RFID Technology with Proof-of-Principle Study
2023: Know Labs’ noninvasive diabetes sensor tech aces proof-of-concept tests
It will provide the user with real-time information on blood glucose levels. This product will require U.S. Food and Drug Administration clearance prior to its introduction to the market.
The Bio-RFID technology can be integrated into a variety of wearable, mobile or bench-top form factors.
The Company’s technology uses spectroscopy to direct electromagnetic energy through a substance or material to capture a unique molecular signature. The Company refers to its technology as Bio-RFID™.
The first application of our Bio-RFID technology will be in a product marketed as a non-invasive glucose monitor.
This patented and patent-pending technology makes it possible to effectively identify and monitor analytes that could only previously be performed by invasive and/or expensive and time-consuming lab-based tests.
Jumps
Finance & Acquisitions: Know Labs
Key People: Know Labs